1. Home
  2. IBRX vs EPAC Comparison

IBRX vs EPAC Comparison

Compare IBRX & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$6.23

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Enerpac Tool Group Corp.

EPAC

Enerpac Tool Group Corp.

HOLD

Current Price

$40.48

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
EPAC
Founded
2014
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IBRX
EPAC
Price
$6.23
$40.48
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$11.80
$50.50
AVG Volume (30 Days)
46.1M
435.4K
Earning Date
03-02-2026
12-17-2025
Dividend Yield
N/A
0.10%
EPS Growth
N/A
0.98
EPS
N/A
1.66
Revenue
$82,555,000.00
$615,911,000.00
Revenue This Year
$680.06
$5.17
Revenue Next Year
$90.18
$5.97
P/E Ratio
N/A
$24.58
Revenue Growth
1025.95
3.91
52 Week Low
$1.83
$35.01
52 Week High
$8.28
$47.47

Technical Indicators

Market Signals
Indicator
IBRX
EPAC
Relative Strength Index (RSI) 75.41 52.32
Support Level $5.71 $40.00
Resistance Level $8.28 $42.43
Average True Range (ATR) 0.67 0.97
MACD 0.42 0.04
Stochastic Oscillator 67.10 48.81

Price Performance

Historical Comparison
IBRX
EPAC

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision hydraulic and mechanical tools, controlled-force products, and heavy lifting solutions. Operating mainly through its Industrial Tools & Services (IT&S) segment, the company designs, manufactures, and distributes branded tools, and offers maintenance, bolting, machining, joint integrity, and equipment rental services across industries such as oil & gas, manufacturing, power generation, and infrastructure. Its key products include hydraulic cylinders, pumps, torque wrenches, and bolt tensioners under the brands ENERPAC and HYDRATIGHT. The company serves customers internationally, with operations in the USA, Australia, Brazil, Germany, Saudi Arabia, the United Kingdom, and other countries, deriving the majority of its revenue from the USA.

Share on Social Networks: